RFL Rafael Holdings Inc

Price (delayed)

$1.64

Market cap

$40.32M

P/E Ratio

14.91

Dividend/share

N/A

EPS

$0.11

Enterprise value

$34.88M

Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through ...

Highlights
The EPS has surged by 138% since the previous quarter and by 122% year-on-year
The net income has soared by 131% since the previous quarter and by 118% year-on-year
Rafael Holdings's quick ratio has shrunk by 71% QoQ and by 50% YoY
The revenue has contracted by 3.5% YoY

Key stats

What are the main financial stats of RFL
Market
Shares outstanding
24.58M
Market cap
$40.32M
Enterprise value
$34.88M
Valuations
Price to earnings (P/E)
14.91
Price to book (P/B)
0.39
Price to sales (P/S)
140.99
EV/EBIT
18.06
EV/EBITDA
17.23
EV/Sales
126.85
Earnings
Revenue
$275,000
EBIT
$1.93M
EBITDA
$2.02M
Free cash flow
-$56.84M
Per share
EPS
$0.11
Free cash flow per share
-$2.4
Book value per share
$4.17
Revenue per share
$0.01
TBVPS
$4.26
Balance sheet
Total assets
$106.15M
Total liabilities
$3.9M
Debt
$1.7M
Equity
$102.25M
Working capital
$71.81M
Liquidity
Debt to equity
0.02
Current ratio
23.01
Quick ratio
22.69
Net debt/EBITDA
-2.69
Margins
EBITDA margin
736%
Gross margin
100%
Net margin
796.7%
Operating margin
-4,095.6%
Efficiency
Return on assets
2.2%
Return on equity
2.2%
Return on invested capital
2.4%
Return on capital employed
1.9%
Return on sales
702.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RFL stock price

How has the Rafael Holdings stock price performed over time
Intraday
1.23%
1 week
-4.09%
1 month
-7.87%
1 year
-16.33%
YTD
-10.38%
QTD
-4.65%

Financial performance

How have Rafael Holdings's revenue and profit performed over time
Revenue
$275,000
Gross profit
$275,000
Operating income
-$11.26M
Net income
$2.19M
Gross margin
100%
Net margin
796.7%
The net margin has soared by 131% from the previous quarter and by 119% YoY
The net income has soared by 131% since the previous quarter and by 118% year-on-year
The company's operating income rose by 40% YoY and by 9% QoQ
The operating margin has increased by 38% YoY and by 8% QoQ

Growth

What is Rafael Holdings's growth rate over time

Valuation

What is Rafael Holdings stock price valuation
P/E
14.91
P/B
0.39
P/S
140.99
EV/EBIT
18.06
EV/EBITDA
17.23
EV/Sales
126.85
The EPS has surged by 138% since the previous quarter and by 122% year-on-year
The P/B is 78% lower than the 5-year quarterly average of 1.8 and 22% lower than the last 4 quarters average of 0.5
RFL's equity is up by 8% QoQ and by 2.1% YoY
The price to sales (P/S) is 16% lower than the 5-year quarterly average of 166.2 and 14% lower than the last 4 quarters average of 162.4
The revenue has contracted by 3.5% YoY

Efficiency

How efficient is Rafael Holdings business performance
RFL's ROA has soared by 130% QoQ and by 120% YoY
The ROE has soared by 130% from the previous quarter and by 118% YoY
The return on sales has surged by 126% since the previous quarter and by 117% year-on-year
The ROIC has soared by 126% since the previous quarter and by 116% year-on-year

Dividends

What is RFL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RFL.

Financial health

How did Rafael Holdings financials performed over time
The total liabilities has soared by 93% YoY
RFL's current ratio has dropped by 72% since the previous quarter and by 50% year-on-year
The debt is 98% less than the equity
RFL's equity is up by 8% QoQ and by 2.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.